FR2861086B1 - Methode d'induction d'une activite arni specifique dans des cellules et acides nucleiques pour sa mise en oeuvre - Google Patents

Methode d'induction d'une activite arni specifique dans des cellules et acides nucleiques pour sa mise en oeuvre

Info

Publication number
FR2861086B1
FR2861086B1 FR0312250A FR0312250A FR2861086B1 FR 2861086 B1 FR2861086 B1 FR 2861086B1 FR 0312250 A FR0312250 A FR 0312250A FR 0312250 A FR0312250 A FR 0312250A FR 2861086 B1 FR2861086 B1 FR 2861086B1
Authority
FR
France
Prior art keywords
cells
implementation
nucleic acids
rnai activity
specific rnai
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0312250A
Other languages
English (en)
Other versions
FR2861086A1 (fr
Inventor
Bellan Annick Harel
Si Ali Slimane Ait
Monsef Benkirane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0312250A priority Critical patent/FR2861086B1/fr
Priority to US10/576,390 priority patent/US20070082864A1/en
Priority to EP04805237A priority patent/EP1678306A1/fr
Priority to PCT/FR2004/002673 priority patent/WO2005040385A1/fr
Priority to CA002543002A priority patent/CA2543002A1/fr
Publication of FR2861086A1 publication Critical patent/FR2861086A1/fr
Application granted granted Critical
Publication of FR2861086B1 publication Critical patent/FR2861086B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR0312250A 2003-10-20 2003-10-20 Methode d'induction d'une activite arni specifique dans des cellules et acides nucleiques pour sa mise en oeuvre Expired - Fee Related FR2861086B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0312250A FR2861086B1 (fr) 2003-10-20 2003-10-20 Methode d'induction d'une activite arni specifique dans des cellules et acides nucleiques pour sa mise en oeuvre
US10/576,390 US20070082864A1 (en) 2003-10-20 2004-10-19 Method for inducing a specific rnai activity in cells and nucleic acids for carrying out said method
EP04805237A EP1678306A1 (fr) 2003-10-20 2004-10-19 METHODE D'INDUCTION D'UNE ACTIVITE ARNi SPECIFIQUE DANS DES CELLULES ET ACIDES NUCLEIQUES POUR SA MISE EN OEUVRE
PCT/FR2004/002673 WO2005040385A1 (fr) 2003-10-20 2004-10-19 METHODE D’INDUCTION D’UNE ACTIVITE ARNi SPECIFIQUE DANS DES CELLULES ET ACIDES NUCLEIQUES POUR SA MISE EN OEUVRE
CA002543002A CA2543002A1 (fr) 2003-10-20 2004-10-19 Methode d'induction d'une activite arni specifique dans des cellules et acides nucleiques pour sa mise en oeuvre

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0312250A FR2861086B1 (fr) 2003-10-20 2003-10-20 Methode d'induction d'une activite arni specifique dans des cellules et acides nucleiques pour sa mise en oeuvre

Publications (2)

Publication Number Publication Date
FR2861086A1 FR2861086A1 (fr) 2005-04-22
FR2861086B1 true FR2861086B1 (fr) 2005-12-30

Family

ID=34385311

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0312250A Expired - Fee Related FR2861086B1 (fr) 2003-10-20 2003-10-20 Methode d'induction d'une activite arni specifique dans des cellules et acides nucleiques pour sa mise en oeuvre

Country Status (5)

Country Link
US (1) US20070082864A1 (fr)
EP (1) EP1678306A1 (fr)
CA (1) CA2543002A1 (fr)
FR (1) FR2861086B1 (fr)
WO (1) WO2005040385A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192938B2 (en) 2005-02-24 2012-06-05 The Ohio State University Methods for quantifying microRNA precursors
IT1397569B1 (it) 2009-12-10 2013-01-16 Icgeb Peptidi e loro derivati che inibiscono il rilascio extracellulare della proteina tat di hiv-1 e la replicazione di hiv-1.
US20170159070A1 (en) * 2013-06-06 2017-06-08 Agency For Science, Technology And Research Transposon for genome manipulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2433680A1 (fr) * 2000-12-28 2002-08-01 Gregory M Arndt Suppression de gene mediee par arn bicatenaire

Also Published As

Publication number Publication date
WO2005040385A1 (fr) 2005-05-06
CA2543002A1 (fr) 2005-05-06
FR2861086A1 (fr) 2005-04-22
EP1678306A1 (fr) 2006-07-12
US20070082864A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
ATE260272T1 (de) Beta-aminsäure-derivate zur verwendung als matrix-metalloproteasen- und tna-alpha-inhibitoren
ITMI20030589A1 (it) Sistema e metodo per il controllo in linea di una macchina
EE200300471A (et) Uus elongaasi geen ja protsess 9-polüküllastumatarasvhapete tootmiseks
DE60142014D1 (de) Methode zum Auffinden von Genvariationen
DE60022237D1 (de) Bidverarbeitungsverfahren und -System und Aufzeichnungsmedium zur Durchfürung des Verfahrens
FR2818409B1 (fr) Procede pour diviser des documents structures en plusieurs parties
ITSV20030023A1 (it) Metodo per l'ottimizzazione di impulsi ad ultrasuoni in
NO20014960D0 (no) Nye fremgangsmåter for behandling
DE60208278D1 (de) System und Verfahren zum Testen von Nukleinsäuremolekülen
EP1885890A4 (fr) Quantification d'acides nucléiques et de protéines au moyen d'étiquettes de masse d'oligonucléotides
FR2847265B1 (fr) Procede de production de l-aminoacides et bacteries utilisees dans ce procede
DE602004011196D1 (de) Verfahren zur reduzierung von acrylamidbildung in thermisch verarbeiteten lebensmitteln
IL166535A0 (en) Modified adamts4 molecules and method of use thereof
EP1622571A4 (fr) Acides nucleiques et proteines correspondantes appelees 109p1d4 utiles dans le traitement et la detection du cancer
FR2853494B1 (fr) Four de cuisson et procede pour sa mise en oeuvre
FR2861086B1 (fr) Methode d'induction d'une activite arni specifique dans des cellules et acides nucleiques pour sa mise en oeuvre
DE60317693D1 (de) Methode und verwendung von thermostabilen rna-ligasen
EP1590437A4 (fr) Acides nucleiques et proteines correspondantes dites 254p1d6b utiles pour la detection et le traitement du cancer
FR2878532B1 (fr) Methode d'adressage d'acides nucleiques vers des plastes
ITPD20040301A1 (it) Metodo ed apparato per la separazione simultanea di molecole biologiche mediante elettroforesi bidimensionale
ITMI20021423A1 (it) Processo per la separazione dell'acqua prodotta nella ossidazione catalitica di idrocarburi aromatici ad acidi aromatici policarbossilici
DK1330525T3 (da) NOD2-nukleinsyrer og proteiner
FR2864536B1 (fr) Procede de preparation de n-alkyl-2 (hydroxy-4-benzoyl)-3 benzofurannes et intermediaires pour sa mise en oeuvre
ATE332395T1 (de) Kulturmedium und verfahren zur bestimmung gram- negativer mikroorganismen
ATE377078T1 (de) Dehiszenzgen und verfahren zur regulierung von dehiszenz

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090630